Cell Transplantation (Aug 2016)

A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for Transplantation

  • Ling-Jia Wang,
  • Tatsuya Kin,
  • Doug O'gorman,
  • A. M. James Shapiro,
  • Bashoo Naziruddin,
  • Morihito Takita,
  • Marlon F. Levy,
  • Andrew M. Posselt,
  • Gregory L. Szot,
  • Omid Savari,
  • Barbara Barbaro,
  • James McGarrigle,
  • Chun Chieh Yeh,
  • Jose Oberholzer,
  • Ji Lei,
  • Tao Chen,
  • Moh Lian,
  • James F. Markmann,
  • Alejandro Alvarez,
  • Elina Linetsky,
  • Camillo Ricordi,
  • A. N. Balamurugan,
  • Gopalakrishnan Loganathan,
  • Joshua J. Wilhelm,
  • Bernhard J. Hering,
  • Rita Bottino,
  • Massimo Trucco,
  • Chengyang Liu,
  • Zaw Min,
  • Yanjing Li,
  • Ali Naji,
  • Luis A. Fernandez,
  • Martynas Ziemelis,
  • Juan S. Danobeitia,
  • J. Michael Millis,
  • Piotr Witkowski

DOI
https://doi.org/10.3727/096368916X691141
Journal volume & issue
Vol. 25

Abstract

Read online

Selection of an optimal donor pancreas is the first key task for successful islet isolation. We conducted a retrospective multicenter study in 11 centers in North America to develop an islet donor scoring system using donor variables. The data set consisting of 1,056 deceased donors was used for development of a scoring system to predict islet isolation success (defined as postpurification islet yield >400,000 islet equivalents). With the aid of univariate logistic regression analyses, we developed the North American Islet Donor Score (NAIDS) ranging from 0 to 100 points. The c index in the development cohort was 0.73 (95% confidence interval 0.70–0.76). The success rate increased proportionally as the NAIDS increased, from 6.8% success in the NAIDS < 50 points to 53.7% success in the NAIDS ≥ 80 points. We further validated the NAIDS using a separate set of data consisting of 179 islet isolations. A comparable outcome of the NAIDS was observed in the validation cohort. The NAIDS may be a useful tool for donor pancreas selection in clinical practice. Apart from its utility in clinical decision making, the NAIDS may also be used in a research setting as a standardized measurement of pancreas quality.